News
PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]November 3, 2025: Safe Chain’s Boyd brothers convicted for drug diversion and falsifying drug pedigrees
The Maryland distributors were convicted at trial in Florida. A federal judged sentenced a pill press seller from China.
[...]October 27, 2025: U.K. regulators bust illicit site making unlicensed retatrutide and tirzepatide pens
Authorities stated this was the largest single seizure of trafficked weight loss medicines worldwide.
[...]October 20, 2025: PSM leadership lends their expertise to scholarly journals
Board member Dr. Kenneth McCall was named an associate editor of the Journal of Pharmacy and Pharmaceutical Sciences; Executive Director Shabbir Safdar joined the editorial board of the Journal of Illicit Trade, Financial Crime, and Compliance.
[...]October 15, 2025: A JAMA study promotes med spa regulation; a new documentary explores fake GLP-1s
A study says IV hydration spas need more oversight. Louisiana residents were hospitalized after receiving black market botulinum toxin injections. Hulu delved into the counterfeit GLP-1 market and Fierce Healthcare covered AFPs.
[...]Prescription Drug Freight Fraud Report, October 2025
What large-scale commercial imports made it into the country between March and August of 2025?
[...]Oregon State Pharmacy Association makes the case for PBM reform, not payment limits
This summer, Brian Mayo, Executive Director of the Oregon State Pharmacy Association (OSPA), made the case for pharmacy benefit manager (PBM) reform as a better way to rein in drug prices.
[...]October 7, 2025: PSM shares prescription drug freight fraud findings with Democratic governors
PSM Executive Director Shabbir Safdar is speaking at the Democratic Governors Association about the threat of unregulated prescription drugs smuggled into the U.S.
[...]Why are price cap proposals on medicines dangerous to pharmacies and patients?
Supply chain complexity means that upper payment limits and Medicare maximum fair prices will fall disproportionately on pharmacies, leading to closures that threaten patient access to care.
[...]September 30, 2025: Florida agency requests $4 million more for $132 million empty warehouse
Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program.
[...]